SSStefan Schoenfelder

Stefan Schoenfelder

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefan Schoenfelder has a total of 319 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Noncanonical enhancers control gene expression and cell fate in human pluripotent stem cells

    by Yang Cao, Oleksandr Dovgusha, Ayyub Ebrahimi, Carmela Rieline V. Cruz, Stephen Bevan, Lukas Widmer, Fereshteh Torabi, Julia Kurlovich, Ignacio Rodríguez-Polo, Soumen Khan, et al.

    Enhancers are key gene regulatory elements that ensure the precise spatiotemporal execution of developmental gene expression programs. However, recent findings indicate that current approaches to identify enhancers may not capture the full repertoire of active enhancers in mammalian genomes. Here, we combine massively parallel enhancer assays with chromatin structure and transcriptome profiling to functionally annotate enhancers genome-wide in human induced pluripotent stem cells. We find that a substantial fraction (∼40%) of accessible chromatin regions with enhancer function lack key features associated with active enhancers, including the active enhancer mark histone H3 lysine-27 acetylation and enhancer-associated RNAs. Perturbation of this class of noncanonical enhancers by CRISPR-mediated epigenome editing or deletion results in decreased levels of target gene expression and, in one instance, loss of pluripotent stem cell characteristics. Collectively, our data demonstrate enhancer activity for a class of gene regulatory elements that had, until now, only been associated with a neutral or inactive status, challenging current models of enhancer function.

  • Open Access

    Author Correction: Epigenetic priming of mammalian embryonic enhancer elements coordinates developmental gene networks

    by Christopher D. Todd, Jannat Ijaz, Fereshteh Torabi, Oleksandr Dovgusha, Stephen Bevan, Olivia Cracknell, Tim Lohoff, Stephen Clark, Ricard Argelaguet, Juliette Pearce, et al.

  • Open Access

    Reversible epiblast regionalization determines differentiation potential of human pluripotent stem cells

    by Magdalena A. Sutcliffe, Eugenia Wong, Steven W. Wingett, Charles A. J. Morris, Harald Stachelscheid, Stefan Schoenfelder, Madeline A. Lancaster

    Although human pluripotent stem cells (hPSCs) can generate all tissues of the body, hPSCs in vitro frequently exhibit differentiation biases or failure that pose substantial challenges for disease modeling and regenerative medicine. The origins of these biases remain incompletely understood and extend beyond reprogramming artifacts. Here we show that loss of default neural differentiation capacity and failure to form brain organoids are linked to erosion of bivalent chromatin marks at developmental gene loci, independent of DNA methylation, driving acquisition of a posterior epiblast-like state and premature developmental gene expression. We develop a chemical chromatin restoration (CHR) approach that rescues this differentiation bias by reinstating transcriptional programs and chromatin landscapes characteristic of the competent anterior epiblast-like state, restoring broad differentiation potential. These findings establish locus-specific patterns of repressive and activating histone post-translational modifications as a tractable and experimentally targetable determinant of hPSC fate competency, and offer an effective route to rescue differentiation-compromised hPSC lines for applications in disease modeling and regenerative medicine.


  • Open Access

    High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk

    by Valeriya Malysheva, Helen Ray-Jones, Nora Lakes, Rachel A. Brown, Tareian A. Cazares, Owen Clay, David E. Ohayon, Pavel Artemov, Joseph A. Wayman, Zi F. Yang, et al.

    Innate lymphoid cells (ILCs) are rare tissue-resident lymphocytes that functionally mirror cells of CD4 + T helper lineage but lack antigen receptors. Type 3 ILCs (ILC3s) are enriched at barrier sites, regulating inflammation and promoting tissue integrity. Here we profile the promoter-anchored chromosomal contacts of primary human ILC3s using low-input, high-resolution targeted chromosome conformation capture and compare them with those in CD4 + T cells. We use these data to link Crohn’s disease genome-wide association study variants with target genes, implicating both known and unanticipated candidates, including CLN3 , a causal gene for Batten disease. We show that Cln3 overexpression in a mouse ILC3-like cell line alters stimulation-induced transcriptional programs and cytokine secretion. Extending our approach to five additional immune genome-wide association study traits reveals enrichment for regulators of ILC3 activation. Our work develops methods, maps long-range gene regulation in ILC3s, and prioritizes immune disease risk genes with roles in this clinically relevant immune cell type.

  • Open Access

    Familial medullary thyroid carcinoma secondary to an SLC30A9 intragenic deletion and translation reinitiation

    by Donato Iacovazzo, Federica Begalli, Oniz Suleyman, Márton Doleschall, Maria Alevizaki, Kevin E. Ashelford, Sherine Awad Mahmoud, Anne Barlier, Sayka Barry, Caroline Brain, et al.

    While most individuals with familial medullary thyroid carcinoma (fMTC) carry RET mutations, in some instances the causative mutations remain unknown. We studied two related families with RET -negative fMTC in 21 affected individuals through linkage analysis, exome/genome sequencing, and high-density array comparative genomic hybridization. We identified a novel heterozygous 40kb intragenic SLC30A9 deletion which segregated with the disease in all affected individuals. The mutant transcript escaped nonsense-mediated decay and resulted in the production of N-terminally truncated proteins via translation reinitiation from in-frame AUG codons located downstream of the deletion. These proteins localized to the endoplasmic reticulum suggesting protein misfolding. Introducing the deletion in an MTC cell line resulted in significant upregulation of genes involved in the unfolded protein response, ER-associated degradation, and the PI3K-Akt pathway. Furthermore, the deletion was associated with increased cell proliferation, migration, and clonogenic capacity, supporting an oncogenic role. These findings expand the genetic background of fMTC beyond RET mutations and implicate translation reinitiation in the etiology of cancer susceptibility syndromes secondary to structural genomic variants.

  • Open Access

    Comprehensive Mapping of Functional Enhancers in Chinese Hamster Ovary Cells

    by María Santos, Yusuf B. Johari, Laura Biggins, Natalie C. Elliott, Stefan Schoenfelder, Mounika Boddireddy, Daniel K. Fabian, Michael Anbar, Peter M. O'CAllaghan, Peter J. Rugg‐Gunn

    Chinese hamster ovary (CHO) cells are the leading mammalian system for recombinant therapeutic protein production. However, optimizing transgene expression remains challenging due to the limited understanding of the regulatory mechanisms controlling gene expression in CHO cells. Towards overcoming this barrier, here we provide a systematic characterization of cis‐regulatory elements in CHO cells. Using genome‐wide STARR‐seq, a high‐throughput method for quantifying enhancer strength, we identified regions with enhancer activity in the CHO cell genome. By integrating these data with ATAC‐seq and histone modification profiles, we were able to characterize the chromatin state of these regions. Our analysis revealed thousands of newly identified enhancer sequences. The most active sequences could drive transgene expression at levels similar to or higher than strong viral enhancers. Notably, half of the regions found to have enhancer activity were within inaccessible chromatin in their native context. We observed that accessible enhancers were primarily near to transcriptional start sites and associated with ubiquitously‐expressed genes, whereas inaccessible enhancers were predominantly intergenic and associated with tissue‐specific genes. Additionally, through a deep‐learning‐based approach ETS and YY1 transcription factor (TF) binding motifs were identified as key determinants of enhancer identity and strength. Disrupting YY1 binding motifs led to reduced enhancer activity, thereby highlighting the importance of YY1 as a transcriptional activator in CHO cells. Our study demonstrates the first comprehensive map of functionally‐validated enhancers in CHO cells and generates new insights into gene regulation and the role of TFs in determining enhancer strength. This study helps to lay the foundation for strategic engineering of CHO cell transcriptional networks to achieve enhanced biopharmaceutical production.


  • Open Access

    Signatures of digital Polycomb regulation in functional iPSC heterogeneity between individuals

    by Ander Movilla Miangolarra, Julia Kurlovich, Fereshteh Torabi, Oleksandr Dovgusha, Yang Cao, Lihan Lin, Ufuk Günesdogan, Stefan Schoenfelder, Martin Howard

    Induced pluripotent stem cells (iPSCs) show substantial heterogeneity between individuals in their capacity to differentiate into various cell types, hindering their translational application. To explore the causes of this variability, we analysed a panel of ten human iPSC lines, evaluating their differentiation efficiency for two different fates, profiling their transcriptome and chromatin state. Using a machine learning approach, we related chromatin state variability with transcriptional differences. We found that regulation of the Polycomb-mediated histone modification H3K27me3 at specific gene loci exhibited the most consistent differences among iPSC lines, frequently displaying a digital ON/OFF pattern, consistent with a mathematical model based on Polycomb read-write feedback. Notably, altered gene expression patterns of Polycomb-regulated genes were largely propagated into an intermediate state in the differentiation trajectory. Finally, we uncovered a subset of Polycomb-regulated genes with heterogeneous expression and chromatin signatures that were highly predictive of iPSC differentiation efficiencies for two cell types.


  • Open Access

    Epigenetic priming of mammalian embryonic enhancer elements coordinates developmental gene networks

    by Christopher D. Todd, Jannat Ijaz, Fereshteh Torabi, Oleksandr Dovgusha, Stephen Bevan, Olivia Cracknell, Tim Lohoff, Stephen Clark, Ricard Argelaguet, Juliette Pierce, et al.

    Background: Embryonic development requires the accurate spatiotemporal execution of cell lineage-specific gene expression programs, which are controlled by transcriptional enhancers. Developmental enhancers adopt a primed chromatin state prior to their activation. How this primed enhancer state is established and maintained and how it affects the regulation of developmental gene networks remains poorly understood. Results: Here, we use comparative multi-omic analyses of human and mouse early embryonic development to identify subsets of postgastrulation lineage-specific enhancers which are epigenetically primed ahead of their activation, marked by the histone modification H3K4me1 within the epiblast. We show that epigenetic priming occurs at lineage-specific enhancers for all three germ layers and that epigenetic priming of enhancers confers lineage-specific regulation of key developmental gene networks. Surprisingly in some cases, lineage-specific enhancers are epigenetically marked already in the zygote, weeks before their activation during lineage specification. Moreover, we outline a generalizable strategy to use naturally occurring human genetic variation to delineate important sequence determinants of primed enhancer function. Conclusions: Our findings identify an evolutionarily conserved program of enhancer priming and begin to dissect the temporal dynamics and mechanisms of its establishment and maintenance during early mammalian development.


  • Open Access

    Non-canonical enhancers control gene expression and cell fate in human pluripotent stem cells

    by Yang Cao, Oleksandr Dovgusha, Ayyub Ebrahimi, Stephen Bevan, Lukas Widmer, Fereshteh Torabi, Julia Kurlovich, Ignacio Rodríguez-Polo, Soumen Khan, Manthan Patel, et al.

    Enhancers are key gene regulatory elements that ensure the precise spatiotemporal execution of developmental gene expression programmes. However recent findings indicate that approaches to identify enhancers may not capture the full repertoire of active enhancers in mammalian genomes. Here, we combine massively parallel enhancer assays with chromatin structure and transcriptome profiling to functionally annotate enhancers genome-wide in human induced pluripotent stem cells. We find that a substantial fraction (∼40%) of accessible chromatin regions with enhancer function lack key features associated with active enhancers, including the active enhancer mark histone H3 lysine 27 acetylation and enhancer-associated RNAs. Perturbation of this class of non-canonical enhancers by CRISPR-mediated epigenome editing results in decreased levels of target gene expression and, in one instance, loss of pluripotent stem cell characteristics. Collectively, our data demonstrate enhancer activity for a class of gene regulatory elements that had until now only been associated with a neutral or inactive status, challenging current models of enhancer function.

  • Open Access

    The KRAB-Zinc Finger protein ZKSCAN3 represses enhancers via embedded retrotransposons

    by Daniel Moore, Eugenia Wong, Charles Arnal, Stefan Walter Schoenfelder, Mikhail Spivakov, Simon Andrews, Maria A. Christophorou

    Summary: Gene cis -regulatory sequences are increasingly recognised as containing “domesticated” transposable elements that impact their function. The KRAB Zinc Finger Protein (KZFP) family of transcription factors is typically associated with transposable element silencing through establishment of heterochromatin. Here, using acute protein depletion in embryonic stem cells, we reveal that the KZFP ZKSCAN3 represses enhancer activity through targeting enhancer-embedded retrotransposons and that ZKSCAN3-mediated repression does not rely on the induction of heterochromatin. ZKSCAN3, which exhibits strong genetic association with the neurodevelopmental disorder schizophrenia, operates during neural differentiation and is necessary for proper cell specification and expression of genes that regulate axon guidance, neuronal motility and pathfinding. These findings define ZKSCAN3 as an enhancer regulator and uncover a heterochromatin-independent KZFP. Additionally, they exemplify how a KZFP epigenetically regulates enhancers in a native setting and highlight how transposable elements and their KZFP binders have shaped gene expression networks.